ResearcherSeoul National UniversityNo recent work listed
Sunjong Han
Matched on ORCID iD 0000-0002-1235-7459; OpenAlex author ID A5068788720. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 3
- Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion. Co-author DOI 10.1016/j.asjsur.2020.07.021↗
- Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer. Co-author DOI 10.23736/s0026-4733.19.07958-6↗
- Actual long-term outcome of T1 and T2 pancreatic ductal adenocarcinoma after surgical resection. Co-author DOI 10.1016/j.ijsu.2017.02.007↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Seok Heo · 3 shared papers, 2017–2021 · strength 0.36
- Paper Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric ve… DOI 10.1016/j.asjsur.2020.07.021↗
- Paper Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer. DOI 10.23736/s0026-4733.19.07958-6↗
- Paper Actual long-term outcome of T1 and T2 pancreatic ductal adenocarcinoma after surgical resection. DOI 10.1016/j.ijsu.2017.02.007↗
- In Woong Han · 3 shared papers, 2017–2021 · strength 0.36
- Paper Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric ve… DOI 10.1016/j.asjsur.2020.07.021↗
- Paper Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer. DOI 10.23736/s0026-4733.19.07958-6↗
- Paper Actual long-term outcome of T1 and T2 pancreatic ductal adenocarcinoma after surgical resection. DOI 10.1016/j.ijsu.2017.02.007↗
- Seong Ho Choi · 3 shared papers, 2017–2021 · strength 0.36
- Paper Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric ve… DOI 10.1016/j.asjsur.2020.07.021↗
- Paper Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer. DOI 10.23736/s0026-4733.19.07958-6↗
- Paper Actual long-term outcome of T1 and T2 pancreatic ductal adenocarcinoma after surgical resection. DOI 10.1016/j.ijsu.2017.02.007↗
- Yung Hun You · 2 shared papers, 2017–2021 · strength 0.24
- Youngju Ryu · 1 shared paper, 2020 · strength 0.13
- San Hyup Han · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.